Fathema Uddin

2.1k total citations · 1 hit paper
7 papers, 727 citations indexed

About

Fathema Uddin is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Fathema Uddin has authored 7 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 1 paper in Organic Chemistry. Recurrent topics in Fathema Uddin's work include Lung Cancer Research Studies (3 papers), RNA modifications and cancer (2 papers) and CRISPR and Genetic Engineering (2 papers). Fathema Uddin is often cited by papers focused on Lung Cancer Research Studies (3 papers), RNA modifications and cancer (2 papers) and CRISPR and Genetic Engineering (2 papers). Fathema Uddin collaborates with scholars based in United States and Japan. Fathema Uddin's co-authors include Triparna Sen, Charles M. Rudin, Nisargbhai Shah, Elisa de Stanchina, Marı́a Contel, Àlvaro Quintanal-Villalonga, Benelita T. Elie, Omar Hayatt, John T. Poirier and Corrin A. Wohlhieter and has published in prestigious journals such as Annals of Oncology, Cell Reports and Journal of Thoracic Oncology.

In The Last Decade

Fathema Uddin

7 papers receiving 715 citations

Hit Papers

CRISPR Gene Therapy: Applications, Limitations, and Impli... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fathema Uddin United States 5 498 224 129 120 87 7 727
Pamela S. VanderVere-Carozza United States 10 738 1.5× 355 1.6× 57 0.4× 120 1.0× 74 0.9× 20 866
Katherine S. Pawelczak United States 13 816 1.6× 387 1.7× 64 0.5× 137 1.1× 79 0.9× 22 945
Amy Goodale United States 9 664 1.3× 159 0.7× 103 0.8× 109 0.9× 68 0.8× 16 861
Yong-Sam Kim South Korea 8 541 1.1× 248 1.1× 35 0.3× 86 0.7× 82 0.9× 9 809
Abel Bermudez United States 11 612 1.2× 105 0.5× 73 0.6× 171 1.4× 37 0.4× 32 797
Go Watanabe United States 15 965 1.9× 255 1.1× 30 0.2× 109 0.9× 103 1.2× 23 1.1k
Morgan E. Diolaiti United States 9 618 1.2× 300 1.3× 25 0.2× 63 0.5× 90 1.0× 20 977
Bianca V. Gapp Austria 7 493 1.0× 81 0.4× 33 0.3× 58 0.5× 93 1.1× 9 619
Giuseppe Leuzzi United States 14 954 1.9× 386 1.7× 22 0.2× 106 0.9× 177 2.0× 17 1.1k

Countries citing papers authored by Fathema Uddin

Since Specialization
Citations

This map shows the geographic impact of Fathema Uddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fathema Uddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fathema Uddin more than expected).

Fields of papers citing papers by Fathema Uddin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fathema Uddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fathema Uddin. The network helps show where Fathema Uddin may publish in the future.

Co-authorship network of co-authors of Fathema Uddin

This figure shows the co-authorship network connecting the top 25 collaborators of Fathema Uddin. A scholar is included among the top collaborators of Fathema Uddin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fathema Uddin. Fathema Uddin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Taniguchi, Hirokazu, Rebecca Caeser, Shweta S. Chavan, et al.. (2022). WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC. Cell Reports. 39(7). 110814–110814. 81 indexed citations
2.
Nguyen, Evelyn M., Hirokazu Taniguchi, Joseph M. Chan, et al.. (2022). Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC. Journal of Thoracic Oncology. 17(8). 1014–1031. 78 indexed citations
3.
Wohlhieter, Corrin A., Fathema Uddin, Àlvaro Quintanal-Villalonga, et al.. (2021). An optimized NGS sample preparation protocol for in vitro CRISPR screens. STAR Protocols. 2(2). 100390–100390. 2 indexed citations
4.
Quintanal-Villalonga, Àlvaro, Maysun Hasan, Shweta S. Chavan, et al.. (2021). 1800O Multi-omic characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation. Annals of Oncology. 32. S1226–S1226. 1 indexed citations
5.
Uddin, Fathema, Charles M. Rudin, & Triparna Sen. (2020). CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future. Frontiers in Oncology. 10. 1387–1387. 354 indexed citations breakdown →
6.
Wohlhieter, Corrin A., Allison L. Richards, Fathema Uddin, et al.. (2020). Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer. Cell Reports. 33(9). 108444–108444. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026